Real-world treatment switching to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: A cohort study

BACKGROUND: Sacubitril/valsartan is an effective treatment for heart failure with reduced ejection fraction (HFrEF) based on clinical trial data. However, little is known about its use or impact in real-world practice. The aim of this study was to describe our routine clinical experience of switchin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganesananthan, Sashiananthan, Shah, Nisar, Shah, Parin, Elsayed, Hossam, Phillips, Julie, Parkes, Ann, Morgan, Angharad, Yousef, Zaheer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537464/
https://www.ncbi.nlm.nih.gov/pubmed/33020255
http://dx.doi.org/10.1136/openhrt-2020-001305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537464/
https://www.ncbi.nlm.nih.gov/pubmed/33020255
http://dx.doi.org/10.1136/openhrt-2020-001305

Ejemplares similares